Evaluation of the effectiveness and transferability of the digital health platform (ProACT) to support home-based multimorbidity self-management in Europe

Not Applicable

• Conditions: Multimorbidity consisting of two or more of any of the following:1. Diabetes2. Chronic Respiratory Disease (i.e., COPD, Chronic Bronchitis, Emphysema, and Chronic Asthma)3. Chronic Heart Disease, Coronary Artery Disease, and Cardiovascular Disease (i.e., Hypertension, Atherosclerosis, Angina, and Arrhythmia)4. Chronic Heart Failure; Not Applicable

• Registration Number: ISRCTN34134007
• Lead Sponsor: Trinity College Dublin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-20
• Last Update Posted: 22 July 2024
• Study Completion: 2025-05-02

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 2220

Inclusion Criteria

Participants with multimorbidity must:
1. Be aged 65 years old and over
2. Possess sufficient cognitive capacity to provide written informed consent
3. Have at least 2 of the following conditions: diabetes, chronic respiratory disease (e.g. chronic obstructive pulmonary disease (COPD), chronic asthma), chronic heart failure, chronic heart disease (e.g., coronary artery disease, cardiovascular disease (including hypertension, atherosclerosis, angina or arrhythmia))

For care network participants to be included, the person with multimorbidity must provide consent for their participation. Care network participants must:
1. Be aged 18-90 years old and over
2. Be providing support to a consented participant with multimorbidity in trial arm 1 (if they are an informal carer, they must be providing support to a participant with multimorbidity for at least six months; and if they are a formal carer, formal care Quality Assistant, or healthcare professional, they must be formally recognised as such and possess at least two years’ experience of professionally working in a relevant health or primary care setting with people with multimorbidity with the same health conditions as those involved in the current trial)
3. Have access to a tablet, smartphone, or computer with an internet connection
4. Possess the skills to use an internet-based application or website
5. Possess sufficient cognitive capacity to provide written informed consent

Partner organisation management and staff must:
1. Be aged 18 or older
2. Be overseeing and/or implementing the delivery of ProACT to their clients with multimorbidity
3. Have access to a tablet, smartphone, or computer with an internet connection
4. Possess the skills to use an internet-based application or website

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Quality of Life measured using the EuroQol EQ-5D-5L questionnaire and Control, Autonomy, Self-realisation and Pleasure Scale (CASP-19) at T1 (baseline) and T7 (at the end of a PwM’s 6-month trial period)<br>2. Healthcare Utilisation measured using a SEURO trial-designed Healthcare Utilisation questionnaire at the beginning of the trial period, once per month during, and at the end of a PwM’s 6-month trial period (at T1, T2, T3, T4, T5, T6, and T7)<br><br>Focus is on exploring cost effectiveness using these outcomes.